Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo‐controlled, double‐blind, multicenter clinical trial

Background: Pharmacological conversion of paroxysmal atrial fibrillation is frequently necessary. The aim of this study was to compare intravenous propafenone, a class Ic antiar‐rhythmic agent, with placebo in paroxysmal atrial fibrillation (AF) of recent onset (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cardiology (Mahwah, N.J.) N.J.), 1996-05, Vol.19 (5), p.409-412
Hauptverfasser: Fresco, Claudio, Proclemer, Alessandro, Pavan, Alessandro, Buia, Gianfranco, Vicentini, Alfredo, Pavan, Daniela, Morgera, Tullio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Pharmacological conversion of paroxysmal atrial fibrillation is frequently necessary. The aim of this study was to compare intravenous propafenone, a class Ic antiar‐rhythmic agent, with placebo in paroxysmal atrial fibrillation (AF) of recent onset (
ISSN:0160-9289
1932-8737
DOI:10.1002/clc.4960190515